The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis

被引:94
|
作者
Schorn, Stephan [1 ]
Demir, Ihsan Ekin [1 ]
Haller, Bernhard [2 ]
Scheufele, Florian [1 ]
Reyes, Carmen Mota [1 ]
Tieftrunk, Elke [1 ]
Sargut, Mine [1 ]
Goess, Ruediger [1 ]
Friess, Helmut [1 ]
Ceyhan, Guralp Onur [1 ]
机构
[1] Tech Univ Munich, Dept Surg, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[2] Tech Univ Munich, Inst Med Stat & Epidemiol, Klinikum Rechts Isar, Munich, Germany
来源
SURGICAL ONCOLOGY-OXFORD | 2017年 / 26卷 / 01期
关键词
Pancreatic cancer; Neural invasion; Survival; Overall survival; Recurrence-free survival; Disease-free-survival; Systematic review; Meta-analysis; LYMPH-NODE RATIO; PAPILLARY MUCINOUS NEOPLASM; LONG-TERM SURVIVAL; PERINEURAL INVASION; PROGNOSTIC-FACTORS; UNFAVORABLE PROGNOSIS; ADJUVANT CHEMOTHERAPY; DISTAL PANCREATECTOMY; DECREASED SURVIVAL; CURATIVE RESECTION;
D O I
10.1016/j.suronc.2017.01.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To assess the impact of neural invasion/NI on overall survival/OS and tumor recurrence in pancreatic ductal adenocarcinoma/PDAC. Summary background data: NI is a histopathological hallmark of PDAC. Although some studies suggested an important role for NI on OS, disease-free/DFS and progression-free survival/PFS in PDAC, there is still no consensus on the actual role of NI on survival and local recurrence in PDAC. Methods: Pubmed, Cochrane library, Ovid and Google Scholar were screened for the terms "pancreatic ductal adenocarcinoma", "pancreatic cancer", "survival", "tumor recurrence" and " perineural invasion". The PreferredeReporting-Items-for-Systematic-review-and-Meta-Analysis/PRISMA-guidelines were used for systematic review and meta-analysis. Articles meeting predefined criteria were critically analysed on relevance, and meta-analyses were performed by pooling univariate and multivariate hazard ratios/HR. Results: A total number of 25 studies on the influence of NI on tumor recurrence, and 121 studies analysing the influence of NI on survival were identified by systematic review. The HR of the univariate (HR 1.88; 95%-CI 1.71-2.07; p < 0.00001) and multivariate meta-analysis (HR 1.68; 95%-CI 1.47-1.92; p < 0.00001) showed a major impact of NI on OS. Likewise, NI was associated with decreased DFS (HR 2.53; 95%-CI: 1.67-3.83; p =0.0001) and PFS (HR 2.41; 95%-CI: 1.73-3.37: p < 0.00001) multivariate meta-analysis. Conclusions: Although the power of this study is limited by missing pathological procedures to assess the true incidence of NI, NI appears to be an independent prognostic factor for OS, DFS and PFS in PDAC. Therefore, NI should be increasingly considered in patient stratification and in the development of novel therapeutic algorithms. (C) 2017 Published by Elsevier Ltd.
引用
收藏
页码:105 / 115
页数:11
相关论文
共 50 条
  • [41] ABO blood type and overall survival in patients with pancreatic adenocarcinoma: A systematic review and meta-analysis
    Correa, Tulio L.
    Cristalli, Marcelo
    Danielian, Pedro Luiz Lage Bodour
    Antunes, Vanio L. J.
    Fernandes, Matheus Vanzin
    Milioli, Natalia Junkes
    Martins, Otavio C.
    De Mesquita, Cynthia Florencio
    Baraldo, Stefano
    Bockorny, Bruno
    [J]. CANCER RESEARCH, 2024, 84 (17)
  • [42] The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis
    Kumar, Swati
    Santos, Ralph J.
    McGuigan, Andrew J.
    Singh, Urvashi
    Johnson, Peter
    Kunzmann, Andrew T.
    Turkington, Richard C.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (05) : 1090 - 1102
  • [43] Efficacy of Cisplatin-Containing Chemotherapy Regimens in Patients of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis
    Rehman, Obaid Ur
    Fatima, Eeshal
    Nadeem, Zain Ali
    Azeem, Arish
    Motwani, Jatin
    Imran, Habiba
    Mehboob, Hadia
    Khan, Alishba
    Usman, Omer
    [J]. JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (02) : 559 - 571
  • [44] CAN MODERATE ALCOHOL CONSUMPTION DECREASE PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) RISK? A SYSTEMATIC REVIEW AND META-ANALYSIS
    Payne, Thomas
    Lam, Stephen
    Hart, Andrew
    [J]. GUT, 2019, 68 : A156 - A156
  • [45] The value of artificial intelligence techniques in predicting pancreatic ductal adenocarcinoma with EUS images: A meta-analysis and systematic review
    Yin, Hua
    Yang, Xiaoli
    Sun, Liqi
    Pan, Peng
    Peng, Lisi
    Li, Keliang
    Zhang, Deyu
    Cui, Fang
    Xia, Chuanchao
    Huang, Haojie
    Li, Zhaoshen
    [J]. ENDOSCOPIC ULTRASOUND, 2023, 12 (01) : 50 - +
  • [46] Dose surgical resection of hepatic metastases bring benefits to pancreatic ductal adenocarcinoma? A systematic review and meta-analysis
    Yu, Xinzhe
    Gu, Jichun
    Fu, Deliang
    Jin, Chen
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2017, 48 : 149 - 154
  • [47] The Role of Resection Margins in Pancreatic Ductal Adenocarcinoma (PDAC): Is 1 Millimeter Enough? A Systematic Review and Meta-analysis
    Kurlinkus, B.
    Ahola, R.
    Zwart, E.
    Halimi, A.
    Yilmaz, B.
    Ceyhan, G. O.
    Laukkarinen, J.
    [J]. PANCREAS, 2019, 48 (10) : 1468 - 1468
  • [48] DUCTAL ADENOCARCINOMA OF THE PROSTATE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INCIDENCE, PRESENTATION AND MANAGEMENT
    Ranasinha, Nithesh M. S.
    Omer, Altan
    Harriss, Eli
    Davies, Lucy
    Chow, Ken
    Chetta, Paolo M.
    Erickson, Andrew
    Mills, Ian G.
    Bryant, Richard
    Hamdy, Freddie
    Murphy, Declan G.
    Loda, Massimo
    Hovens, Christopher M.
    Corcoran, Niall M.
    Verrill, Clare
    Lamb, Alastair D.
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E1032 - E1033
  • [49] Prognostic Role of High-Grade Tumor Budding in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis with a Focus on Epithelial to Mesenchymal Transition
    Lawlor, Rita T.
    Veronese, Nicola
    Nottegar, Alessia
    Malleo, Giuseppe
    Smith, Lee
    Demurtas, Jacopo
    Cheng, Liang
    Wood, Laura D.
    Silvestris, Nicola
    Salvia, Roberto
    Scarpa, Aldo
    Luchini, Claudio
    [J]. CANCERS, 2019, 11 (01)
  • [50] Intraperitoneal chemotherapy in the management of pancreatic adenocarcinoma: A systematic review and meta-analysis
    Frassini, Simone
    Calabretto, Francesca
    Granieri, Stefano
    Fugazzola, Paola
    Vigano, Jacopo
    Fazzini, Nicola
    Ansaloni, Luca
    Cobianchi, Lorenzo
    [J]. EJSO, 2022, 48 (09): : 1911 - 1921